These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8597519)

  • 1. Decreased angiotensin II receptors mediate decreased vascular response in hepatocellular cancer.
    Wu Y; Cahill PA; Sitzmann JV
    Ann Surg; 1996 Feb; 223(2):225-31. PubMed ID: 8597519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of regional angiotensin-II: a novel biologic response modifier.
    Wu Y; Sitzmann JV
    Ann Surg Oncol; 1996 Jan; 3(1):24-8. PubMed ID: 8770298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered angiotensin-II receptors in human hepatocellular and hepatic metastatic colon cancers.
    Sitzmann JV; Wu Y; Cameron JL
    Ann Surg; 1994 May; 219(5):500-6; discussion 506-7. PubMed ID: 7514393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased pressor reactivity to angiotensin II in cirrhotic rats. Evidence for a post-receptor defect in angiotensin action.
    Murray BM; Paller MS
    Circ Res; 1985 Sep; 57(3):424-31. PubMed ID: 2992836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatic hemodynamic changes in liver cancer patients during intrahepatic arterial angiotensin II infusion induced hypertension and chemoembolization].
    Jiang XQ; Yin GF; Lu XX
    Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):647-9. PubMed ID: 7774400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of decreased vascular reactivity to angiotensin II in conscious, potassium-deficient rats.
    Paller MS; Douglas JG; Linas SL
    J Clin Invest; 1984 Jan; 73(1):79-86. PubMed ID: 6690484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic arterial haemodynamics changes following intra-arterial angiotensin II infusion: duplex/colour Doppler sonography.
    Leen E; Angerson WJ; Warren H; Goldberg JA; Leiberman DP; Cooke TG; McArdle CS
    Clin Radiol; 1993 May; 47(5):321-4. PubMed ID: 8508593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation by angiotensin II of its receptors in resistance blood vessels.
    Gunther S; Gimbrone MA; Alexander RW
    Nature; 1980 Sep; 287(5779):230-2. PubMed ID: 6253796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The afferent circulation of the liver in patients with primary hepatocellular carcinoma.
    Jakab F; Ráth Z; Schmal F; Nagy P; Faller J
    Hepatogastroenterology; 1995; 42(4):399-402. PubMed ID: 8586376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in hepatic hemodynamics due to primary liver tumours.
    Jakab F; Ráth Z; Schmal F; Nagy P; Faller J
    HPB Surg; 1996; 9(4):245-8. PubMed ID: 8809587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood flow measurement in patients with hepatocellular carcinomas.
    Jakab F; Ráth Z; Schmal F; Nagy P; Faller J
    Acta Chir Hung; 1994; 34(1-2):87-94. PubMed ID: 7604633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duplex/colour Doppler sonography: measurement of changes in hepatic arterial haemodynamics following intra-arterial angiotensin II infusion.
    Leen E; Angerson WJ; Warren HW; Goldberg JA; Sutherland GR; Cooke TG; McArdle CS
    Br J Cancer; 1993 Jun; 67(6):1381-4. PubMed ID: 8512823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and hemodynamic implications of renal vascular angiotensin II receptors in SHR.
    Haddad G; Garcia R
    J Mol Cell Cardiol; 1996 Feb; 28(2):351-61. PubMed ID: 8729067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heparan N-sulfotransferase in diabetic liver: role of angiotensin II.
    Williams KJ; Liu ML; Zhu Y; Xu X; Davidson WR; McCue P; Sharma K
    Diabetes; 2005 Apr; 54(4):1116-22. PubMed ID: 15793251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Arterial Infusion of Low-Density Lipoprotein Docosahexaenoic Acid Nanoparticles Selectively Disrupts Redox Balance in Hepatoma Cells and Reduces Growth of Orthotopic Liver Tumors in Rats.
    Wen X; Reynolds L; Mulik RS; Kim SY; Van Treuren T; Nguyen LH; Zhu H; Corbin IR
    Gastroenterology; 2016 Feb; 150(2):488-98. PubMed ID: 26484708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory GTP-binding regulatory protein Gi3 can couple angiotensin II receptors to inhibition of adenylyl cyclase in hepatocytes.
    Pobiner BF; Northup JK; Bauer PH; Fraser ED; Garrison JC
    Mol Pharmacol; 1991 Aug; 40(2):156-67. PubMed ID: 1908548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional angiotensin II receptors in cultured vascular smooth muscle cells.
    Gunther S; Alexander RW; Atkinson WJ; Gimbrone MA
    J Cell Biol; 1982 Feb; 92(2):289-98. PubMed ID: 6277961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II vascular receptors in fetal and neonatal rats.
    Ghiani P; Uva BM; Mandich A; Masini MA
    Cell Biochem Funct; 1988 Oct; 6(4):283-7. PubMed ID: 3191586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Angiotensin II receptor (author's transl)].
    Yazaki Y; Shimada K
    Nihon Rinsho; 1979 Oct; 37(10):3483-91. PubMed ID: 230372
    [No Abstract]   [Full Text] [Related]  

  • 20. Pressor and mesenteric arterial hyporesponsiveness to angiotensin II is an early event in haemorrhagic hypotension in anaesthetised rats.
    Pieber D; Horina G; Sandner-Kiesling A; Pieber TR; Heinemann A
    Cardiovasc Res; 1999 Oct; 44(1):166-75. PubMed ID: 10615400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.